Retatrutide

Retatrutide is an investigational triple GLP-1, GIP and glucagon receptor agonist commonly studied in metabolic research involving incretin signalling, glucose homeostasis, energy expenditure and body-weight regulation pathways. Lianhua Peptide Co. — Hangzhou · Zhejiang · China — supplies Retatrutide for laboratory research with cGMP manufacturing standards, >98% purity specifications, HPLC-MS quality analysis, practical box ordering and tracked international fulfilment.

For laboratory and research use only. Not for human or animal consumption.